LUNG CANCERS ASSOCIATED WITH THOROTRAST EXPOSURE - HIGH-INCIDENCE OF SMALL-CELL CARCINOMA AND IMPLICATIONS FOR ESTIMATION OF RADON RISK

被引:9
|
作者
ISHIKAWA, Y
MORI, T
KATO, Y
TSUCHIYA, E
MACHINAMI, R
SUGANO, H
KITAGAWA, T
机构
[1] CANC INST,DEPT PATHOL,TOSHIMA KU,TOKYO 170,JAPAN
[2] NATL INST RADIOL SCI,CHIBA 260,JAPAN
[3] UNIV TOKYO,DEPT PATHOL,TOKYO 113,JAPAN
关键词
D O I
10.1002/ijc.2910520413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The widely accepted concept that the alpha-emitting radionuclide radon (Rn-222, Rn-220) induces lung cancers in humans has been based on the excess of lung tumours observed in underground miners extracting uranium or other substances. However, this poses the important: question of whether radon is the only carcinogenic factor because such miners are also heavily exposed to mine dusts including silicates, diesel exhaust, etc. in their working environment. Patients to whom Thorotrast was administered continuously exhale radon (Rn-220) derived from Th-232 deposits in the body and therefore provide a good model for lung carcinogenesis by radon without concomitant dust exposure. We therefore investigated lung-cancer incidence in our epidemiological follow-up series, analysing the histological types of 11 lung cancers which were found among 359 Thorotrast autopsy cases and measuring radioactivity in the breath of living Thorotrast patients. The study revealed that, while the proportion of small-cell lung cancers considered to be related to alpha-particles was significantly increased, the overall lung cancer incidence was not significantly higher than in controls, in spite of the high level of Rn-220 in the patients' breath. This result suggests that radon in the lung does induce cancers (particularly small-cell carcinomas) but that the induction rate is not as high as expected from risk factors associated with mining. Thus, excess lung cancers among the miners might be related to the combined effects of exposure to radon and mine dusts, and not solely to radon.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 50 条
  • [41] mTOR expression is associated with high survival in small cell lung carcinoma patients
    Carvalho, L.
    Monteiro, J. M.
    Alarcao, A.
    Ladeirinha, A.
    Ferreira, T.
    D'Aguiar, J.
    Silva, M. Reis
    Sousa, V.
    Balseiro, S.
    VIRCHOWS ARCHIV, 2016, 469 : S327 - S327
  • [42] A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma
    Isaka, Mitsuhiro
    Nakagawa, Kazuo
    Ohde, Yasuhisa
    Okumura, Takehiro
    Watanabe, Reiko
    Ito, Ichiro
    Nakajima, Takashi
    Kondo, Haruhiko
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2012, 41 (04) : 841 - 846
  • [43] Motor neuron disease: A paraneoplastic process associated with anti-Hu antibody and small-cell lung carcinoma
    Verma, A
    Berger, JR
    Snodgrass, S
    Petito, C
    ANNALS OF NEUROLOGY, 1996, 40 (01) : 112 - 116
  • [44] Clinical RNA Panel Detects High Expression of Genes Associated with Small-Cell Lung Cancer Subtypes
    Boyle, T.
    Alontaga, A.
    Ozakinci, H.
    Cano, P.
    Koomen, J.
    Chiappori, A.
    Haura, E.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2023, 25 (11): : S91 - S92
  • [45] VARIABLE CONTENT OF HISTAMINASE, L-DOPA DECARBOXYLASE AND CALCITONIN IN SMALL-CELL CARCINOMA OF LUNG - BIOLOGIC AND CLINICAL IMPLICATIONS
    BAYLIN, SB
    WEISBURGER, WR
    EGGLESTON, JC
    MENDELSOHN, G
    BEAVEN, MA
    ABELOFF, MD
    ETTINGER, DS
    NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (03): : 105 - 110
  • [46] Radon, Tobacco Exposure and Non-Small Cell Lung Cancer Risk Related to BER and NER Genetic Polymorphisms
    Enjo-Barreiro, Jose Ramon
    Ruano-Ravina, Alberto
    Perez-Rios, Monica
    Kelsey, Karl
    Varela-Lema, Leonor
    Torres-Duran, Maria
    Parente-Lamelas, Isaura
    Provencio-Pulla, Mariano
    Vidal-Garcia, Iria
    Pineiro-Lamas, Maria
    Fernandez-Villar, Jose A.
    Barros-Dios, Juan M.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2022, 58 (04): : 311 - 322
  • [47] HIGH-DOSE-RATE BRACHYTHERAPY FOR NON SMALL-CELL LUNG CARCINOMA: A RETROSPECTIVE STUDY OF 226 PATIENTS
    Gulcher, Maud Aumont-le
    Prevost, Bernard
    Sunyach, Marie Pierre
    Peiffert, Didier
    Maingon, Philippe
    Thomas, Laurence
    Williaume, Daniele
    Begue, Mickael
    Lerouge, Delphine
    Campion, Loic
    Mahe, Marc-Andre
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (04): : 1112 - 1116
  • [48] Variations in the MHC Region Confer Risk to Esophageal Squamous Cell Carcinoma on the Subjects from High-Incidence Area in Northern China
    Shen, Fang-Fang
    Yue, Wen-Bin
    Zhou, Fu-You
    Pan, Ying
    Zhao, Xue-Ke
    Jin, Yan
    Song, Xin
    Li, Bei
    Han, Xue-Na
    Tang, Sa
    Li, Yan
    Yuan, Guo
    Chen, Li-Sha
    Liu, Ya-Li
    Hu, Yan-Long
    Li, Xiu-Min
    Ren, Jing-Li
    Wang, Li-Dong
    PLOS ONE, 2014, 9 (03):
  • [49] A NOVEL ANTIGEN DEFINED BY MONOCLONAL-ANTIBODY CR101 IS ASSOCIATED WITH SMALL-CELL LUNG-CARCINOMA
    ROSE, C
    WAKSAL, H
    GOLDSTEIN, NI
    HYBRIDOMA, 1994, 13 (03): : 221 - 227
  • [50] DEGRADATION OF GASTRIN RELEASING PEPTIDE BY A MEMBRANE-ASSOCIATED PEPTIDASE IN HUMAN SMALL-CELL LUNG-CARCINOMA CELLS
    KING, DM
    KANE, MA
    CLINICAL RESEARCH, 1991, 39 (01): : A68 - A68